rs6959895
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs6975391
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs7148539
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs765547
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.
|
27790247 |
2016 |
rs7703051
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.
|
27790247 |
2016 |
rs799165
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.
|
27790247 |
2016 |
rs8082812
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.
|
27790247 |
2016 |
rs8129326
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs9323205
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs9376307
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs9599474
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs971535
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs9851042
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
rs874945
|
|
|
0.050 |
GeneticVariation |
BEFREE |
However, there is no significant association between SNPs variants and cancer risk under any five genetic models for rs4759314, rs1899663 and rs874945.
|
30941992 |
2019 |
rs874945
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The results showed that cancer risk was elevated in recessive mutation of rs12826786 (TT vs CC+CT: OR =1.55, 95% CI =1.19, 2.03; TT+CT vs CC: OR =1.23, 95% CI =1.04, 1.46; TT vs CC: OR =1.67, 95% CI =1.24, 2.24; T vs C: OR =1.24, 95% CI =1.09, 1.40) and rs920778 (TT vs CC+CT: OR =1.73, 95% CI =1.30, 2.30; TT+CT vs CC: OR =1.40, 95% CI =1.16, 1.70; TT vs CC: OR =1.83, 95% CI =1.25, 2.68; T vs C: OR =1.37, 95% CI =1.18, 1.59), while the results for polymorphisms of rs7958904, rs4759314, rs874945, and rs1899663 were insignificant.
|
29497311 |
2018 |
rs874945
|
|
|
0.050 |
GeneticVariation |
BEFREE |
HOTAIR SNP rs920778, rs7958904 and rs8749</span>45 are susceptible to cancer risk.
|
27965458 |
2017 |
rs874945
|
|
|
0.050 |
GeneticVariation |
BEFREE |
However, no significant association was found between the rs1899663, rs874945, and rs4759314 polymorphisms and susceptibility of cancer.
|
29463216 |
2018 |
rs874945
|
|
|
0.050 |
GeneticVariation |
BEFREE |
However, no significant association was identified between the rs874945, rs4759314 and rs1899663 polymorphisms and cancer susceptibility.
|
27791260 |
2017 |
rs12826786
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Our meta-analysis showed that HOTAIR polymorphisms of rs12826786 and rs920778 were correlated with increased cancer risk, while rs7958904, rs4759314, rs874945, and rs1899663 were not.
|
29497311 |
2018 |
rs12826786
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The HOTAIR single nucleotide polymorphisms (SNPs) rs920778 (C > T) and rs12826786 (C > T) present in the intronic enhancer and promoter regions of HOTAIR, respectively, are associated with expression, cancer susceptibility, and patient prognosis in some tumor types.
|
28083786 |
2017 |
rs12826786
|
|
|
0.030 |
GeneticVariation |
BEFREE |
For the rs12826786 polymorphism, we identified it significantly increased susceptibility to cancer risk in all genetic models rather than heterozygous models.
|
29463216 |
2018 |
rs2046210
|
|
|
0.020 |
GeneticVariation |
BEFREE |
With the exception of rs2046210 at 6q25.1, the seven other SNPs showed a stronger association with ER-positive than ER-negative cancer.
|
23535825 |
2013 |
rs2046210
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In The Cancer Genome Atlas samples, the AA/AG risk genotypes of SNP rs2046210 were associated with a significantly higher expression level of the AKAP12 gene and a lower level of the ESR1 gene in tumor tissue.
|
26645718 |
2016 |
rs2069514
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The results showed that no significant associations with the risk of cancer were found in any model (allele contrast, codominant, dominant, or recessive model) in terms of rs2069514 and rs3569413 when all studies were pooled into a meta-analysis.
|
23462460 |
2013 |
rs2069514
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The previously published data on the association between CYP1A2*1C (rs2069514) and CYP1A2*1F (rs762551) polymorphisms and cancer risk have remained controversial.
|
25472037 |
2015 |